RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration
MIne was just an opinion as is everyone else on this board.
But good thing that Note's and Azzaks are the only ones that count and make sense....
Oh yeah I almost forgot, we were approved 7 years ago for an mbc phase 3 trial with a spa and even though we have the biomarker we are now still 7 years later looking for guidance....
Tell me , all knowing, just how much shareholder value has this great managment added in the last 7 years since taking the reign, and remember we are only down about 90% since that time.
As I have said before I believe that onc has potential, the issue is the way managmenet has handled it IMO of course.